Selection of patients with cystic fibrosis for lung transplantation

Current Opinion in Pulmonary Medicine

Volumn 8, Issue 6, 2002, Pages 535-541

  Liou, Theodore G ^a   Cahill, Barbara C ^a   Adler, Frederick R ^a   Marshall, Bruce C ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTIFICIAL VENTILATION; BURKHOLDERIA CEPACIA; CADAVER; CRITICAL ILLNESS; CYSTIC FIBROSIS; DEMOGRAPHY; DISEASE EXACERBATION; FORCED EXPIRATORY VOLUME; HUMAN; LIVING DONOR; LUNG INSUFFICIENCY; LUNG TRANSPLANTATION; MULTIDRUG RESISTANCE; NUTRITIONAL STATUS; OUTCOMES RESEARCH; PATIENT SELECTION; PREDICTION; QUALITY OF LIFE; REVIEW; SURVIVAL;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CYSTIC FIBROSIS; FEMALE; HUMANS; LUNG TRANSPLANTATION; MALE; PATIENT SELECTION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; QUALITY OF LIFE; RESPIRATORY FUNCTION TESTS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS;

EID: 0036838818     PISSN: 10705287     EISSN: None     Source Type: Journal    
DOI: 10.1097/00063198-200211000-00009     Document Type: Review

References (35)

1. The U.S. Organ Procurement and Transplantation Network and The Scientific Registry of Transplant Recipients: 2001 Annual Report of the U.S. Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients: Transplant Data 1991-2000. Department of Health and Human Services, Health Resources and Services Administration, Office of Special Programs, Division of Transplantation, Rockville, MD; United Network for Organ Sharing, Richmond, VA; University Renal Research and Education Association, Ann Arbor, MI.
2. Maurer JR, Frost AE, Glanville AR, et al.: International guidelines for the selection of lung transplant candidates. Am J Respir Crit Care Med 1998, 158:335-339.
3. Yankaskas JR, Mallory Jr GB, the Consensus Committee: Lung transplantation in cystic fibrosis. Chest 1998, 113;217-226.
4. Liou TG, Adler FR, Cahill BC, et al.: Survival effect of lung transplantation for patients with cystic fibrosis. JAMA 2001, 286:2686-2689.
5. Shwachman H, Kulczycki LL: Long-term study of one hundred five patients with cystic fibrosis. J Dis Child 1958, 96:6-15.
6. Taussig LM, Kattwinkel J, Friedewald WT, et al.: A new prognostic score and clinical evaluation system for cystic fibrosis. J Pediatr 1973, 82:380-390.
7. Huang NN, Schidlow DV, Szatrowski TH, et al.: Clinical features, survival rate, and prognostic factors in young adults with cystic fibrosis. Am J Med 1987, 82:871-878.
8. Kerem E, Reisman J, Corey M, et al.: Prediction of mortality in patients with cystic fibrosis. New Engl J Med 1992, 326:1187-1191.
9. Corey M, Farewell V: Determinants of mortality from cystic fibrosis in Canada, 1970-1989. Am J Epidemiol 1996, 143:1007-1017.
10. Rosenfeld M, Davis R, FitzSimmons S, et al.: Gender gap in cystic fibrosis mortality. Am J Epidemiol 1997, 145:794-803.
11. Liou TG, Adler FR, Fitzsimmons SC, et al.: Predictive five year survivorship model of cystic fibrosis. Am J Epidemiol 2001, 153:345-352.
12. Milla CE, Warwick WJ: Risk of death in cystic fibrosis patients with severely compromised lung function. Chest 1998, 113:1230-1234.
13. 1 may adversely affect overall survival. Chest 1999, 115:782-787.
14. Hayllar KM, Williams SGJ, Wise AE, et al.: A prognostic model for the prediction of survival in cystic fibrosis. Thorax 1997, 52:313-317.
15. Cohen LF, di Sant'Agrese PA, Friedlander J: Cystic fibrosis and pregnancy: A national survey. Lancet 1980, 2:842-844,
16. Fuchs HJ, Borowitz DS, Christiansen DH, et al.: Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group. New Engl J Med 1994, 331:637-642.
17. Ramsey BW, Pepe MS, Quan JM, et al.: Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. New Engl J Med 1999, 340:23-30.
18. Aris RM, Routh JC, LiPuma JJ, et al.: Lung transplantation for cystic fibrosis patients with Burkholderia cepacia complex: Survival linked to genomovar type. Am J Respir Crit Care Med 2001, 164:2102-2106.
19. Barr ML, Baker CJ, Schenkel FA, et al.: Living donor lung transplantation: Selection, technique, and outcome. Transplant Proc 2001, 33:3527-3532.
20. Barr ML, Schenkel FA, Cohen RG, et al.: Bilateral lobar transplantation utilizing living related donors. Artif Organs 1996, 20:1110-1111.
21. Starnes VA, Barr ML, Cohen RG, et al.: Living-donor lobar lung transplantation experience: Intermediate results. J Thorac Cardiovasc Surg 1996, 112:1284-1291.
22. Shapiro BJ, Veeraraghavan S, Barbers RG: Lung transplantation for cystic fibrosis: An update and practical considerations for referring candidates. Curr Opin Pulm Med 1999, 5:365-370.
23. Aris RM, Gilligan PH, Neuringer IP, et al.: The effects of panresistant bacteria in cystic fibrosis patients on lung transplant outcome. Am J Respir Crit Care Med 1997, 155:1699-1704.
24. Snell GI, de Hoyos A, Krajden M, et al.: Pseudomonas cepacia in lung transplant recipients with cystic fibrosis. Chest 1993, 103:466-471.
25. Chaparro C, Maurer J, Gutierrez C, et al.: Infection with Burkholderia cepacia in cystic fibrosis: Outcome following lung transplantation. Am J Respir Crit Care Med 2001, 163:43-48.
26. Isles A, Maclusky I, Corey M, et al.: Pseudomonas cepacia infection in cystic fibrosis: An emerging problem. J Pediatr 1984, 104:206-210.
27. Thomassen MJ, Demko CA, Klinger JD, et al.: Pseudomonas cepacia colonization among patients with cystic fibrosis. Am Rev Respir Dis 1985, 131:791-796.
28. Whiteford ML, Wilkinson JD, McColl JH, et al.: Outcome of Burkholderia (Pseudomonas) cepacia colonization in children with cystic fibrosis following a hospital outbreak. Thorax 1995, 50:1194-1198.
29. Massard G, Shennib H, Metras D, et al.: Double-lung transplantation in mechanically ventilated patients with cystic fibrosis. Ann Thorac Surg 1993, 55:1087-1092.
30. Sood N, Paradowski U, Yankaskas JR: Outcomes of intensive care unit care in adults with cystic fibrosis. Am J Respir Crit Care Med 2001, 163:335-338.
31. Maish AB: Priorities for lung transplantation among patients with cystic fibrosis. JAMA 2002, 287:1524.
32. Busschbach JJ, Horikx PE, van den Bosch JMM, et al.: Measuring the quality of life before and after bilateral lung transplantation in patients with cystic fibrosis. Chest 1994, 105:911-917.
33. Gross C, Savik K, Bolman RM, et al.: Long-term health status and quality of life outcomes of lung transplant recipients. Chest 1995, 108:1587-1593.
34. Cohen L, Littlefield C, Kelly P, et al.: Predictors of quality of life and adjustment after lung transplantation. Chest 1998, 113:633-644.
35. Liou TG, Adler FR, Cahill BC, et al.: Priorities for lung transplantation among patients with cystic fibrosis. JAMA 2002, 287:1525.